Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

109.35
+4.624.41%
Post-market: 109.350.00000.00%19:30 EDT
Volume:483.38K
Turnover:52.51M
Market Cap:1.60B
PE:-12.32
High:110.41
Open:106.45
Low:105.04
Close:104.73
52wk High:155.29
52wk Low:26.20
Shares:14.67M
Float Shares:8.64M
Volume Ratio:1.88
T/O Rate:5.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.8768
EPS(LYR):-9.0434
ROE:-1773.60%
ROA:-43.61%
PB:-30.28
PE(LYR):-12.09

Loading ...

May 24, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Correspondence

Form CORRESP - Correspondence
May 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Major Issues Report

Form 8-K - Current report
May 10, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2024

Correspondence

Form CORRESP - Correspondence
Mar 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2024

Major Issues Report

Form 8-K - Current report
Mar 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities